{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:32:33Z","timestamp":1783823553533,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00405-018-5110-5","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T06:25:18Z","timestamp":1535696718000},"page":"2719-2726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma"],"prefix":"10.1007","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-9104","authenticated-orcid":false,"given":"Anupam","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash Chandra","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashoak Mani","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"5110_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00405-006-0202-z","volume":"264","author":"R Schuon","year":"2007","unstructured":"Schuon R, Brieger J, Heinrich UR, Roth Y, Szyfter W, Mann WJ (2007) Immunohistochemical analysis of growth mechanisms in juvenile angiofibroma. Eur Arch Otorhinolaryngol 264:389\u2013394","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"5110_CR2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1288\/00005537-199208000-00016","volume":"102","author":"M Schiff","year":"1992","unstructured":"Schiff M, Gonzalez AM, Ong M, Baird A (1992) Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: basic FGF. Laryngoscope 102:940\u2013945","journal-title":"Laryngoscope"},{"key":"5110_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/archotol.126.6.723","volume":"126","author":"DG Dillard","year":"2000","unstructured":"Dillard DG, Cohen C, Muller S, Del Gaudio J, Reichman O, Parrish B et al (2000) Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 126:723\u2013725","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"5110_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.6823562","volume":"219","author":"DR Senger","year":"1983","unstructured":"Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983\u2013985","journal-title":"Science"},{"key":"5110_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","volume":"92","author":"S Soker","year":"1998","unstructured":"Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735\u2013745","journal-title":"Cell"},{"key":"5110_CR6","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1091\/mbc.e09-12-1061","volume":"22","author":"B Herzog","year":"2011","unstructured":"Herzog B, Pellet-Many C, Britton G, Hartzoulakis B, Zachary IC (2011) VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Mol Biol Cell 22:2766\u20132776","journal-title":"Mol Biol Cell"},{"key":"5110_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2014.08.001","volume":"397","author":"BF Palmer","year":"2014","unstructured":"Palmer BF, Clegg DJ (2014) Oxygen sensing and metabolic homeostasis. Mol Cell Endocrinol 397:51\u201358","journal-title":"Mol Cell Endocrinol"},{"key":"5110_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/gtc.12055","volume":"18","author":"E Matsumoto","year":"2013","unstructured":"Matsumoto E, Sasaki S, Kinoshita H, Kito T, Ohta H, Konishi M et al (2013) Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16. Genes Cells 18:544\u2013553","journal-title":"Genes Cells"},{"key":"5110_CR9","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2741\/4077","volume":"17","author":"L Xiao","year":"2012","unstructured":"Xiao L, Du Y, Shen Y, He Y, Zhao H, Li Z (2012) TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2\/ERK pathway. Front Biosci (Landmark Ed) 17:2667\u20132674","journal-title":"Front Biosci (Landmark Ed)"},{"key":"5110_CR10","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1755-1536-5-2","volume":"5","author":"D Warburton","year":"2012","unstructured":"Warburton D (2012) Developmental responses to lung injury: repair or fibrosis. Fibrogenesis Tissue Repair 5:S2","journal-title":"Fibrogenesis Tissue Repair"},{"key":"5110_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1164\/rccm.200811-1794OC","volume":"180","author":"VV Gupte","year":"2009","unstructured":"Gupte VV, Ramasamy SK, Reddy R, Lee J, Weinreb PH, Violette SM et al (2009) Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 180:424\u2013436","journal-title":"Am J Respir Crit Care Med"},{"key":"5110_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1083\/jcb.95.1.162","volume":"95","author":"SK Lemmon","year":"1982","unstructured":"Lemmon SK, Riley MC, Thomas KA, Hoover GA, Maciag T, Bradshaw RA (1982) Bovine fibroblast growth factor: comparison of brain and pituitary preparations. J Cell Biol 95:162\u2013169","journal-title":"J Cell Biol"},{"key":"5110_CR13","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1073\/pnas.82.19.6409","volume":"82","author":"KA Thomas","year":"1985","unstructured":"Thomas KA, Rios-Candelore M, Gimenez-Gallego G, DiSalvo J, Bennett C, Rodkey J et al (1985) Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci USA 82:6409\u20136413","journal-title":"Proc Natl Acad Sci USA"},{"key":"5110_CR14","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.1073\/pnas.82.18.6138","volume":"82","author":"AB Schreiber","year":"1985","unstructured":"Schreiber AB, Kenney J, Kowalski WJ, Friesel R, Mehlman T, Maciag T (1985) Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. Proc Natl Acad Sci USA 82:6138\u20136142","journal-title":"Proc Natl Acad Sci USA"},{"key":"5110_CR15","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1083\/jcb.101.4.1623","volume":"101","author":"AB Schreiber","year":"1985","unstructured":"Schreiber AB, Kenney J, Kowalski J, Thomas KA, Gimenez-Gallego G, Rios-Candelore M et al (1985) A unique family of endothelial cell polypeptide mitogens: the antigenic and receptor cross-reactivity of bovine endothelial cell growth factor, brain-derived acidic fibroblast growth factor, and eye-derived growth factor-II. J Cell Biol 101:1623\u20131626","journal-title":"J Cell Biol"},{"key":"5110_CR16","unstructured":"Kumar V (2010) Robbins and coltran pathologic basis of disease. Elsevier, Beijing, pp 88\u201389 (ISBN: 978-1-4160-3121-5)"},{"key":"5110_CR17","first-page":"44","volume":"2","author":"JB Demoulin","year":"2012","unstructured":"Demoulin JB, Montano-Almendras CP (2012) Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis. Am J Blood Res 2:44\u201356","journal-title":"Am J Blood Res"},{"key":"5110_CR18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1101\/gad.1653708","volume":"22","author":"J Andrae","year":"2008","unstructured":"Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276\u20131312","journal-title":"Genes Dev"},{"key":"5110_CR19","first-page":"1","volume":"989","author":"M Hannink","year":"1989","unstructured":"Hannink M, Donoghue DJ (1989) Structure and function of platelet-derived growth factor (PDGF) and related proteins. Biochim Biophys Acta 989:1\u201310","journal-title":"Biochim Biophys Acta"},{"key":"5110_CR20","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1002\/j.1460-2075.1992.tb05523.x","volume":"11","author":"CH Heldin","year":"1992","unstructured":"Heldin CH (1992) Structural and functional studies on platelet-derived growth factor. EMBO J 11:4251\u20134259","journal-title":"EMBO J"},{"key":"5110_CR21","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.5858\/2003-127-1480-GFARIJ","volume":"127","author":"PJ Zhang","year":"2003","unstructured":"Zhang PJ, Weber R, Liang H, Pasha TL, LiVolsi VA (2003) Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps. Arch Pathol Lab Med 127:1480\u20131484","journal-title":"Arch Pathol Lab Med"},{"key":"5110_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/00313020802035857","volume":"40","author":"J Pauli","year":"2008","unstructured":"Pauli J, Gundelach R, Vanelli-Rees A, Rees G, Campbell C, Dubey S et al (2008) Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell. Pathology 40:396\u2013400","journal-title":"Pathology"},{"key":"5110_CR23","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1517\/14728222.2012.725047","volume":"16","author":"D Ribatti","year":"2012","unstructured":"Ribatti D, Ranieri G, Basile A, Azzariti A, Paradiso A, Vacca A (2012) Tumor endothelial markers as a target in cancer. Expert Opin Ther Targets 16:1215\u20131225","journal-title":"Expert Opin Ther Targets"},{"key":"5110_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J (2003) Targeting RAS signaling pathways in cancer therapy. Nat Rev Cancer 3:11\u201322","journal-title":"Nat Rev Cancer"},{"key":"5110_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ccr.2005.04.030","volume":"7","author":"KH Lim","year":"2005","unstructured":"Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD et al (2005) Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7:533\u2013545","journal-title":"Cancer Cell"},{"key":"5110_CR26","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1101\/gad.993902","volume":"16","author":"NM Hamad","year":"2002","unstructured":"Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT,.et al (2002) Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 16:2045\u20132057","journal-title":"Genes Dev"},{"key":"5110_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0964-1955(95)00065-8","volume":"32","author":"IC Paterson","year":"1996","unstructured":"Paterson IC, Eveson JW, Prime SS (1996) Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral Oncol 32:150\u2013153","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"5110_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1017\/S0022215116000268","volume":"130","author":"A Mishra","year":"2016","unstructured":"Mishra A, Mishra SC (2016) Changing trends in the incidence of juvenile nasopharyngeal angiofibroma: seven decades of experience at King George\u2019s Medical University, Lucknow, India. J Laryngol Otol 130:363\u2013368","journal-title":"J Laryngol Otol"},{"key":"5110_CR29","doi-asserted-by":"crossref","unstructured":"Mishra A, Jaiswal R, Pandey A, Mishra SC (2018) Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review. Eur Arch Otolaryngol (submitted)","DOI":"10.1007\/s00405-018-5178-y"},{"key":"5110_CR30","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1002\/lary.26250","volume":"127","author":"P Pandey","year":"2017","unstructured":"Pandey P, Mishra A, Tripathi AM, Verma V, Trivedi R, Singh HP et al (2017) Current molecular profile of juvenile nasopharyngeal angiofibroma: first comprehensive study from India. Laryngoscope 127:e100\u2013e106","journal-title":"Laryngoscope"},{"key":"5110_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1017\/S0022215116000773","volume":"130","author":"A Mishra","year":"2016","unstructured":"Mishra A, Mishra SC, Verma V, Singh HP, Kumar S, Tripathi AM et al (2016) In defence of transpalatal, transpalatal-circumaxillary (transpterygopalatine) and transpalatal-circumaxillary-sublabial approaches to lateral extensions of juvenile nasopharyngeal angiofibroma. J Laryngol Otol 130:462\u2013473","journal-title":"J Laryngol Otol"},{"key":"5110_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1001\/archotol.1996.01890140012004","volume":"122","author":"D Radkowski","year":"1996","unstructured":"Radkowski D, McGill T, Healy GB, Ohlms L, Jones DT (1996) Angiofibroma: changes in staging and treatment. Arch Otolaryngol Head Neck Surg 122:122\u2013129","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"5110_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1017\/S0022215100110497","volume":"103","author":"SC Mishra","year":"1989","unstructured":"Mishra SC, Shukla GK, Bhatia N, Pant MC (1989) A rational classification of angiofibromas of the postnasal space. J Laryngol Otol 103:912\u2013916","journal-title":"J Laryngol Otol"},{"issue":"9","key":"5110_CR34","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1017\/S0022215117001372","volume":"13","author":"A Mishra","year":"1989","unstructured":"Mishra A, Mishra SC, Pandey A (2017) Variations in molecular expressions of juvenile nasopharyngeal angiofibroma. J Laryngol Otol 131(9):752\u2013759","journal-title":"J Laryngol Otol"},{"key":"5110_CR35","doi-asserted-by":"crossref","unstructured":"Mishra A, Verma V (2018) Implication of embolization in residual disease in lateral extension of juvenile nasopharyngeal angiofibroma. J Oral Biol Craniofacial Res (submitted)","DOI":"10.1016\/j.jobcr.2018.12.001"},{"key":"5110_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijporl.2005.06.007","volume":"70","author":"G Saylam","year":"2006","unstructured":"Saylam G, Yucel OT, Sungur A, Onerci M (2006) Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 70:227\u2013234","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"5110_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/archotol.130.6.727","volume":"130","author":"J Brieger","year":"2004","unstructured":"Brieger J, Wierzbicka M, Sokolov M, Roth Y, Szyfter W, Mann WJ (2004) Vessel density, proliferation and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 130:727\u2013731","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"5110_CR38","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/modpathol.3880459","volume":"14","author":"ZK Arbiser","year":"2001","unstructured":"Arbiser ZK, Arbiser JL, Cohen C, Gal AA (2001) Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis. Mod Pathol 14:1195\u20131199","journal-title":"Mod Pathol"},{"key":"5110_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/030089160108700111","volume":"87","author":"G Juric","year":"2001","unstructured":"Juric G, Zarkovic N, Nola M, Tillian M, Juki\u0107 S (2001) The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors. Tumori 87:47\u201353","journal-title":"Tumori"},{"key":"5110_CR40","first-page":"1","volume":"30","author":"A Mishra","year":"2016","unstructured":"Mishra A, Singh V, Verma V, Pandey S, Trivedi R, Singh HP et al (2016) Current status and Clinical correlation of beta-catenin in juvenile nasopharyngeal angiofibroma. J Laryngol Otol 30:1\u20137","journal-title":"J Laryngol Otol"},{"key":"5110_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1615\/CritRevOncog.2013007182","volume":"18","author":"V Profumo","year":"2013","unstructured":"Profumo V, Gandellini P (2013) MicroRNAs: cobblestones on the road to cancer metastasis. Crit Rev Oncog 18:341\u2013355","journal-title":"Crit Rev Oncog"},{"key":"5110_CR42","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1371\/journal.pmed.0050019","volume":"5","author":"K Pietras","year":"2008","unstructured":"Pietras K, Pahler J, Bergers G, Hanahan D (2008) Functions of paracrine PDGF signalling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med 5:e19","journal-title":"PLoS Med"},{"key":"5110_CR43","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ncb1288","volume":"7","author":"S Song","year":"2005","unstructured":"Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G (2005) PDGFRb\u00fe perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 7:870\u2013879","journal-title":"Nat Cell Biol"},{"key":"5110_CR44","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1038\/sj.emboj.7600289","volume":"23","author":"J Dong","year":"2004","unstructured":"Dong J, Grunstein J, Tejada M, Peale F, Frantz G, Liang WC et al (2004) VEGF null cells require PDGFR alpha signaling mediated stromal fibroblast recruitment for tumorigenesis. EMBO J 23:2800\u20132810","journal-title":"EMBO J"},{"key":"5110_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00005537-199602000-00016","volume":"106","author":"MA Nagai","year":"1996","unstructured":"Nagai MA, Butugan O, Logullo A, Brentani MM (1996) Expression of growth factors, protooncogenes and p53 in nasopharyngeal angiofibromas. Laryngoscope 106:190\u2013195","journal-title":"Laryngoscope"},{"key":"5110_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.lungcan.2007.01.029","volume":"56","author":"A L\u00f3pez-Martin","year":"2007","unstructured":"L\u00f3pez-Martin A, Ballest\u00edn C, Garcia-Carbonero R, Casta\u00f1o A, Lopez-R\u00edos F, L\u00f3pez-Encuentra A et al (2007) Prognostic value of Kit expression in small cell lung cancer. Lung Cancer 56:405\u2013413","journal-title":"Lung Cancer"},{"key":"5110_CR47","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/onc.2012.290","volume":"32","author":"WK Chau","year":"2013","unstructured":"Chau WK, Ip CK, Mak AS, Lai HC, Wong AS (2013) c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt\/\u03b2-catenin-ATP-binding cassette G2 signaling. Oncogene 32:2767\u20132781","journal-title":"Oncogene"},{"key":"5110_CR48","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1593\/neo.08618","volume":"10","author":"C Wiesner","year":"2008","unstructured":"Wiesner C, Nabha SM, Dos Santos EB, Yamamoto H, Meng H, Melchior SW et al (2008) c-Kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis. Neoplasia 10:996\u20131003","journal-title":"Neoplasia"},{"key":"5110_CR49","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3109\/1354750X.2013.838307","volume":"18","author":"P Cheng","year":"2013","unstructured":"Cheng P, Chen H, Liu SR, Pu XY (2013) A ZC. SNPs in KIT and KITLG genes may be associated with oligospermia in Chinese population. Biomarkers 18:650\u2013654","journal-title":"Biomarkers"},{"key":"5110_CR50","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1146\/annurev.bi.61.070192.004113","volume":"61","author":"KB Marcu","year":"1992","unstructured":"Marcu KB, Bossone SA, Patel AJ (1992) Myc function and regulation. Annu Rev Biochem 61:809\u2013860","journal-title":"Annu Rev Biochem"},{"key":"5110_CR51","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"TC He","year":"1998","unstructured":"He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509\u20131512","journal-title":"Science"},{"key":"5110_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","volume":"111","author":"M Wetering van de","year":"2002","unstructured":"van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A et al (2002) The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241\u2013250","journal-title":"Cell"},{"key":"5110_CR53","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1101\/gad.287404","volume":"18","author":"OJ Sansom","year":"2004","unstructured":"Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP et al (2004) Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation and migration. Genes Dev 18:1385\u20131390","journal-title":"Genes Dev"},{"key":"5110_CR54","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic Ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593\u2013602","journal-title":"Cell"},{"key":"5110_CR55","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1128\/MCB.23.7.2530-2542.2003","volume":"23","author":"PJ Mitchell","year":"2003","unstructured":"Mitchell PJ, Perez-Nadales E, Malcolm DS, Lloyd AC (2003) Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype. Mol Cell Biol 23:2530\u20132542","journal-title":"Mol Cell Biol"},{"key":"5110_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1590\/S1516-31801999000300004","volume":"117","author":"CM Coutinho","year":"1999","unstructured":"Coutinho CM, Bassini AS, Gutie\u00b4rrez LG, Butugan O, Kowalski LP, Brentani MM et al (1999) Genetic alterations in Ki-ras and Ha-ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancer. Sao Paulo Med J 117:113\u2013120","journal-title":"Sao Paulo Med J"},{"key":"5110_CR57","first-page":"453","volume":"13","author":"B Schick","year":"2005","unstructured":"Schick B, Veldung B, Wemmert S, Jung V, Montenarh M, Meese E et al (2005) p53 and Her-2\/neu in juvenile angiofibromas. Oncol Rep 13:453\u2013457","journal-title":"Oncol Rep"},{"key":"5110_CR58","first-page":"317","volume":"37","author":"A Mishra","year":"2016","unstructured":"Mishra A, Sachadeva M, Jain A, Shukla NM, Pandey A (2016) Human papilloma virus in juvenile nasopharyngeal angiofibroma: possible recent trend. Am J Otolaryngol Head Neck Med Surg 37:317\u2013322","journal-title":"Am J Otolaryngol Head Neck Med Surg"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-018-5110-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-018-5110-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-018-5110-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:23:56Z","timestamp":1661905436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-018-5110-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["5110"],"URL":"https:\/\/doi.org\/10.1007\/s00405-018-5110-5","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"20 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}